RLG2019

Topics • Strategy

At the end of the third quarter, the chemical industry continues to face an economic slowdown, compounded by international trade conflicts, increased political uncertainty, and fundamental changes to the value chain (e. g. the case of electro-mobility.)

Topics • Strategy

CEFIC’s Mid-Century Vision

Topics • Strategy

Catalyzing Growth and Addressing Sustainability Challenges

Top-Feature

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

MOC – Event Center Messe München

A successful concept on course for expansion — maintenance Munich 2025

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.